Whats New

New revalidation tool for GPs to attain QOF points and tackle myths of stroke prevention in AF www.af-revalidation.org

A new e-learning tool to help GPs complete critical steps for revalidation is launched today at the National Association of Primary Care (NAPC) Best Practice meeting. Not only does the tool guide revalidation preparation, it also contributes to CPD and facilitates the achievement of QOF points for AF care. Ultimately, helping ensure the best care for AF patients at risk of stroke. Registration and use of the tool is free.

Read more »

Patients with a common heart rhythm disorder called atrial fibrillation (AF) have a five times greater risk of suffering a stroke.

Watch this new video to see Eve Knight from AntiCoagulation Europe; Professor John Camm from St. George's Hospital, UK and Trudie Lobban from Atrial Fibrillation Association discuss the importance of preventing AF-related strokes.

Read more »

Sorting the facts from the myths about the new oral anticoagulants

Read some of the reasons that patients are being given when they are denied access to the new oral anticoagulants

Read more »

Commissioning effective anticoagulation services for the future: A resource pack for commissioners

A Resource pack for commissioners of anticoagulation services in the UK Read or download the resource pack from the publications section of the site.

Read more »

New anticoagulation e-learning programme from the British Journal of Cardiology

‘Understanding anticoagulation’ is a new modular e-learning programme from the British Journal of Cardiology (BJC). The programme has been developed for health care professionals (HCPs) and can be accessed free at www.bjcardio.co.uk/learning. Click on heading above and click on the link

Read more »

Rivaroxaban (Xarelto®) treatment of pulmonary embolism (PE) and prevention of a recurrent PE (and DVT) in adults

Rivaroxaban (Xarelto®) has been recommended in final published guidance by the National Institute for Health and Care Excellence (NICE) for the treatment of pulmonary embolism (PE) and prevention of a recurrent PE (and DVT) in adults.

Read more »

Risk of deep vein thrombosis with hormone replacement therapy

Women taking hormone replacement therapy should be assessed for their risk of developing deep vein thrombosis

Read more »

Boehringer Ingelheim submits to European Medicines Agency for Dabigatran

Application submitted to the European Medicines Agency (EMA) for use of dabigatran etexilate in treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE

Read more »

The NHS has broken its constitutional promise to over 80,000 patients as new research shows they are at risk of being denied their right to new, lifesaving blood clot drugs. Access to potentially lifesaving drugs for the treatment and prevention of blood clots is being blocked by local NHS organisations

64 per cent of GPs had encountered barriers to prescribing the three new Oral Anticoagulants (medicines for blood clots).

Read more »

Sign the E-petition to get free prescriptions for people on long term anticoagulation therapy.

The cost of prescription charges in England will rise by 20p to £7.85 from 1 April In other parts of the UK prescriptions are free. Sign the E-petition to get free prescriptions for people on long term anticoagulation therapy. http://epetitions.direct.gov.uk/petitions/46432

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space